Chinese General Practice ›› 2023, Vol. 26 ›› Issue (06): 734-741.DOI: 10.12114/j.issn.1007-9572.2022.0630
• Big Data Research • Previous Articles Next Articles
Received:
2022-05-23
Revised:
2022-09-30
Published:
2023-02-20
Online:
2022-10-13
Contact:
RANG Weiqing
About author:
通讯作者:
让蔚清
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0630
人群 | 年份(年) | APC(95%CI)(%) | Z值 | P值 | AAPC(95%CI)(%) | Z值 | P值 |
---|---|---|---|---|---|---|---|
总人群 | 2000—2014 | -1.02(-1.08,-0.96) | -34.06 | <0.001 | -0.68(-0.76,-0.60) | -16.68 | <0.001 |
2014—2019 | 0.27(-0.01,0.55) | 2.03 | 0.060 | ||||
男性 | 2000—2004 | -0.16(-0.52,0.20) | -0.99 | 0.346 | -0.47(-0.66,0.29) | -5.11 | <0.001 |
2004—2007 | -1.33(-2.24,-0.24) | -2.74 | 0.023 | ||||
2007—2015 | -0.60(-0.74,-0.46) | -9.57 | <0.001 | ||||
2015—2019 | 0.11(-0.20,0.42) | 0.81 | 0.441 | ||||
女性 | 2000—2006 | -1.55(-1.73,-1.37) | -18.87 | <0.001 | -0.87(-0.96,-0.79) | -19.17 | <0.001 |
2006—2014 | -1.21(-1.35,-1.07) | -19.10 | <0.001 | ||||
2014—2019 | 0.49(0.27,0.71) | 4.88 | <0.001 |
Table 1 Trends of ASMR of brain cancers in the whole population,male and female populations in China from 2000 to 2019
人群 | 年份(年) | APC(95%CI)(%) | Z值 | P值 | AAPC(95%CI)(%) | Z值 | P值 |
---|---|---|---|---|---|---|---|
总人群 | 2000—2014 | -1.02(-1.08,-0.96) | -34.06 | <0.001 | -0.68(-0.76,-0.60) | -16.68 | <0.001 |
2014—2019 | 0.27(-0.01,0.55) | 2.03 | 0.060 | ||||
男性 | 2000—2004 | -0.16(-0.52,0.20) | -0.99 | 0.346 | -0.47(-0.66,0.29) | -5.11 | <0.001 |
2004—2007 | -1.33(-2.24,-0.24) | -2.74 | 0.023 | ||||
2007—2015 | -0.60(-0.74,-0.46) | -9.57 | <0.001 | ||||
2015—2019 | 0.11(-0.20,0.42) | 0.81 | 0.441 | ||||
女性 | 2000—2006 | -1.55(-1.73,-1.37) | -18.87 | <0.001 | -0.87(-0.96,-0.79) | -19.17 | <0.001 |
2006—2014 | -1.21(-1.35,-1.07) | -19.10 | <0.001 | ||||
2014—2019 | 0.49(0.27,0.71) | 4.88 | <0.001 |
年份(年) | CMR (1/10万) | 累加序列 | 滑动平均序列 | 指数规律性检验(级比) | 光滑性检验(光滑比) |
---|---|---|---|---|---|
2000 | 3.59 | 3.59 | — | — | — |
2001 | 3.62 | 7.20 | 5.39 | 2.01 | 1.01 |
2002 | 3.64 | 10.84 | 9.02 | 1.51 | 0.51 |
2003 | 3.64 | 14.48 | 12.66 | 1.34 | 0.34 |
2004 | 3.68 | 18.16 | 16.32 | 1.25 | 0.25 |
2005 | 3.69 | 21.85 | 20.00 | 1.20 | 0.20 |
2006 | 3.68 | 25.53 | 23.69 | 1.17 | 0.17 |
2007 | 3.70 | 29.24 | 27.38 | 1.15 | 0.15 |
2008 | 3.75 | 32.98 | 31.11 | 1.13 | 0.13 |
2009 | 3.79 | 36.78 | 34.88 | 1.12 | 0.12 |
2010 | 3.83 | 40.61 | 38.70 | 1.10 | 0.10 |
2011 | 3.85 | 44.46 | 42.54 | 1.09 | 0.09 |
2012 | 3.88 | 48.34 | 46.40 | 1.09 | 0.09 |
2013 | 3.91 | 52.25 | 50.30 | 1.08 | 0.08 |
2014 | 3.99 | 56.25 | 54.25 | 1.08 | 0.08 |
2015 | 4.05 | 60.30 | 58.27 | 1.07 | 0.07 |
2016 | 4.15 | 64.45 | 62.38 | 1.07 | 0.07 |
2017 | 4.24 | 68.69 | 66.57 | 1.07 | 0.07 |
2018 | 4.35 | 73.05 | 70.87 | 1.06 | 0.06 |
2019 | 4.47 | 77.51 | 75.28 | 1.06 | 0.06 |
Table 2 Sequence and feasibility test of crude mortality rate of brain cancers in China from 2000 to 2019
年份(年) | CMR (1/10万) | 累加序列 | 滑动平均序列 | 指数规律性检验(级比) | 光滑性检验(光滑比) |
---|---|---|---|---|---|
2000 | 3.59 | 3.59 | — | — | — |
2001 | 3.62 | 7.20 | 5.39 | 2.01 | 1.01 |
2002 | 3.64 | 10.84 | 9.02 | 1.51 | 0.51 |
2003 | 3.64 | 14.48 | 12.66 | 1.34 | 0.34 |
2004 | 3.68 | 18.16 | 16.32 | 1.25 | 0.25 |
2005 | 3.69 | 21.85 | 20.00 | 1.20 | 0.20 |
2006 | 3.68 | 25.53 | 23.69 | 1.17 | 0.17 |
2007 | 3.70 | 29.24 | 27.38 | 1.15 | 0.15 |
2008 | 3.75 | 32.98 | 31.11 | 1.13 | 0.13 |
2009 | 3.79 | 36.78 | 34.88 | 1.12 | 0.12 |
2010 | 3.83 | 40.61 | 38.70 | 1.10 | 0.10 |
2011 | 3.85 | 44.46 | 42.54 | 1.09 | 0.09 |
2012 | 3.88 | 48.34 | 46.40 | 1.09 | 0.09 |
2013 | 3.91 | 52.25 | 50.30 | 1.08 | 0.08 |
2014 | 3.99 | 56.25 | 54.25 | 1.08 | 0.08 |
2015 | 4.05 | 60.30 | 58.27 | 1.07 | 0.07 |
2016 | 4.15 | 64.45 | 62.38 | 1.07 | 0.07 |
2017 | 4.24 | 68.69 | 66.57 | 1.07 | 0.07 |
2018 | 4.35 | 73.05 | 70.87 | 1.06 | 0.06 |
2019 | 4.47 | 77.51 | 75.28 | 1.06 | 0.06 |
[1] |
赫捷,魏文强. 2019中国肿瘤登记年报[M]. 北京:人民卫生出版社,2019:193-197.
|
[2] |
|
[3] |
沈洪兵. 肿瘤分子流行病学[M]. 北京:人民卫生出版社,2014.
|
[4] |
|
[5] |
韩仁强,周金意,郑荣寿,等. 2014年中国脑瘤发病与死亡分析[J]. 中国肿瘤,2019,28(3):161-166. DOI:10.11735/j.issn.1004-0242.2019.03.A001.
|
[6] |
韩仁强,周金意,张思维,等. 2015年中国脑瘤发病与死亡分析[J]. 中国肿瘤,2021,30(1):29-34. DOI:10.11735/j.issn.1004-0242.2021.01.A002.
|
[7] | |
[8] |
|
[9] |
屈彦,王天一,杨津,等. GBD数据库的数据提取方法与流程[J]. 中国循证心血管医学杂志,2019,11(9):1043-1046. DOI:10.3969/j.issn.1674-4055.2019.09.04.
|
[10] |
GBD Demographics Collaborators. Global age-sex-specific fertility,mortality,healthy life expectancy (HALE),and population estimates in 204 countries and territories,1950-2019:a comprehensive demographic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1160-1203. DOI:10.1016/S0140-6736(20)30977-6.
|
[11] |
|
[12] |
许忠宇. 2001~2015年深圳市肺癌发病的年龄-时期-队列模型分析[D]. 武汉:华中科技大学,2018.
|
[13] |
|
[14] |
|
[15] |
|
[16] |
邓聚龙. 灰色系统理论教程[M]. 武汉:华中理工大学出版社,1990.
|
[17] |
张鹏,李颖男. GM(1,1)模型的优化与应用[J]. 太原师范学院学报(自然科学版),2021,20(4):14-19,54.
|
[18] |
刘丽娜. 灰色GM(1,1)模型的优化及其应用[D]. 秦皇岛:燕山大学,2014.
|
[19] |
何家赓,侯建忠,闫贻忠. 2005—2013年中国肿瘤登记地区女性乳腺癌死亡及疾病负担时间趋势分析[J]. 中华肿瘤防治杂志,2019,26(8):523-528. DOI:10.16073/j.cnki.cjcpt.2019.08.001.
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
国家卫生健康委老龄健康司. 2020年度国家老龄事业发展公报[EB/OL].(2021-10-15)[2022-07-02].
|
[27] |
|
[28] |
张云飞,刘培民. 中医药治疗脑瘤的研究进展[J]. 中医临床研究,2015,7(29):145-146.
|
[29] |
|
[30] |
GBD Brain and Other CNS Cancer Collaborators. Global,regional,and national burden of brain and other CNS cancer,1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol,2019,18(4):376-393. DOI:10.1016/S1474-4422(18)30468-X.
|
[31] |
|
[32] |
|
[33] |
|
[34] |
查震球,刘志荣,郑荣寿,等. 2008—2012年中国肿瘤登记地区脑及神经系统肿瘤发病与死亡分析[J]. 中华疾病控制杂志,2018,22(11):1101-1105. DOI:10.16462/j.cnki.zhjbkz.2018.11.003.
|
[1] | ZHU Wenpeng, HAN Mengqi, WANG Yuxin, WANG Guoping. Trends and Projections of Incidence and Mortality of Nasopharyngeal Carcinoma in China from 1990 to 2019 [J]. Chinese General Practice, 2023, 26(34): 4269-4276. |
[2] | WANG Zhen, SHEN Guoqi, LI Yanan, ZHU Yinghua, QIU Hang, ZHENG Di, XU Tongda, LI Wenhua. Development and Validation of a Risk Prediction Model for Contrast-induced Acute Kidney Injury after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction [J]. Chinese General Practice, 2023, 26(29): 3650-3656. |
[3] | LI Zimeng, WANG Rong, CHEN Shuai, ZHAO Caili, WANG Xiaocong, WEN Yalu, LIU Long. Application of metaPRS and APOEε4 to Optimize Genetic Risk Prediction Modeling Strategy for Mild Cognitive Impairment [J]. Chinese General Practice, 2023, 26(25): 3104-3111. |
[4] | HU Xiaofei, ZHAO Ping, CAO Tinghua, PENG Lanlan. Study on the Predictive Value of Abdominal Fat Content and Distribution in the Acute Pancreatitis and Its Severity [J]. Chinese General Practice, 2023, 26(21): 2614-2619. |
[5] | SHEN Aomei, LU Qian, FU Xin, WEI Xiaoxia, BIAN Jingru, ZHANG Liyuan, QIANG Wanmin, PANG Dong. Constructing a Risk Prediction Model of Breast Cancer-related Lymphedema Based on a Meta-analysis of Prospective Cohort Studies [J]. Chinese General Practice, 2023, 26(17): 2078-2088. |
[6] | WANG Hongxin, FAN Wenlong, YANG Xiaoyu, CHEN Dongyu, HUANG Qiao, PAN Suyue, WANG Pu, HU Min, HE Yuqing. Protein-energy Malnutrition Incidence in China: Trend in 1990-2019 and Future Trend in 2020-2029 [J]. Chinese General Practice, 2023, 26(05): 591-597. |
[7] | ZHAO Honglin, LI Qiaomei, LI Tingting, DING Guowu. AIDS in China from 2004 to 2018: Incidence and Mortality Trends and Age-period-cohort Effect Analysis [J]. Chinese General Practice, 2023, 26(04): 409-416. |
[8] | LIU Xuewei, WANG Yuan, WEI Danmei, LU Wenli. Age-Period-Cohort Analysis of Trends of Breast Cancer Incidence and Mortality among Chinese Females from 1990 to 2019 [J]. Chinese General Practice, 2023, 26(01): 34-41. |
[9] | HE Ting, YUAN Li, YANG Xiaoling, YE Ziwei, LI Rao, GU Yan. Risk Prediction Models for Type 2 Diabetes in Asian Adults: a Systematic Review [J]. Chinese General Practice, 2022, 25(34): 4267-4277. |
[10] | Yongjian WANG, Weijing QI, Yipeng WANG, Sha HUANG, Cong LI, Na WEI, Jie HU. Classification and Comparative Analysis of Prediction Models for Postpartum Depression [J]. Chinese General Practice, 2022, 25(24): 3036-3042. |
[11] | Yan RAO, Meiqi YAO, Dawei JIANG, Cui MAO. Development and Validation of a Risk Prediction Model of Post-stroke Acute Kidney Injury [J]. Chinese General Practice, 2022, 25(23): 2885-2891. |
[12] | Chuangyi ZHAO, Kongjun YUAN, Yuan YANG, Guangqing ZHOU, Haiyan LI. The Burden of Chronic Obstructive Pulmonary Disease in China Predicted by ARIMA and NNAR Models: a Comparative Study [J]. Chinese General Practice, 2022, 25(16): 1942-1949. |
[13] | Jinyao WANG, Nianping ZHANG, Zhiqiang BAI, Zhenkun WANG. Age-Period-Cohort Analysis of Secular Trends of Cervical Cancer Incidence and Mortality in China, 1993—2017 [J]. Chinese General Practice, 2022, 25(13): 1564-1568. |
[14] | Qian ZOU, Miaomiao GENG, Yanhong ZHU. Development and External Validation of an Evidence-based Risk Prediction Model for Multidrug-resistant Bacterial Infections in ICU Patients [J]. Chinese General Practice, 2022, 25(12): 1441-1448. |
[15] |
YU Wenkai, CHEN Jianlin, LEI Rui, LUO Wei, HU Min, LIU Deng, ZHU Yu, CHEN Qi.
A Comparative Study on the Accuracy of Prognosis of the End-of-life Assessment Form and Common Survival Prediction Scales in Advanced Cancer Patients [J]. Chinese General Practice, 2022, 25(07): 851-858. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||